lung cancer

The V Foundation's Victory Ride to Cure Cancer was back as a LIVE cycling event and celebration, Aug. 28. Team DCI "virtual" and in-person riders raised more than $20K.

Lung cancer advocates came together Aug. 1 to build, paint and decorate ribbons for lung cancer awareness. Next to keep hope alive at LUNGe Forward, Sept. 18.

The NC Lung Cancer Initiative presents an educational webinar on clinical trials in lung cancer. Neal Ready, MD, is a featured speaker.

Neelima Navuluri, MD, MPH, receives NCCN Foundation Young Investigator Award for her project to improve lung cancer screening among Black Veterans.

Scott Balderson, PA-C, shares why he’s excited for his new role as president of the Association of Physician Assistants in Cardiothoracic and Vascular Surgery.

In the age of Covid, Community Outreach & Engagement at DCI comes of age, team expands with disparities researcher/associate director

In an open letter, the NCCN, ACS, and major U.S. cancer centers, inc. DCI, urge public to resume cancer screening & treatment during pandemic.

Joab Odera, PhD, a postdoctoral researcher in DCI's Patierno/Freedman/George Lab is among 13 Duke scientists named to list of 1,000 inspiring Black scientists.

As the COVID-19 pandemic shines a light on health disparities, efforts to find new ways to reduce them get a boost.

Thomas A. D’Amico, MD, director of DCI's Thoracic Oncology program, has been appointed medical director, American Association for Thoracic Surgery,

A breast cancer researcher's study of estrogen action may lead to better treatments for other cancers.

Kevin Oeffinger, MD, is guest co-editor of a new book covering colorectal, lung, cervical, prostate, skin cancer, and ovarian cancer screening.

This holiday season, two stage 4 lung cancer survivors share their inspirational stories of healing and how they are passing on the gift.

A Duke research team has identified a molecular process by which lung cancer cells metastasize to the brain.

A decade since it’s discovery in the Patz Lab, a first-in-class, novel targeted immunotherapy developed at DCI, is now in a phase 1b clinical trial.

Who should get screened and what happens if something is found ?

Daniel Sullivan, MD, professor emeritus in the Duke University Department of Radiology, received an award from the Prevent Cancer Foundation, on Oct. 28.

One top trainee from each of the eight DCI Research Programs presented their pioneering cancer research projects. Benjamin Mayro received the Bell Award.

Duke Raleigh Hospital is Survivor, Families & Friends sponsor for the Lung Cancer Initiative NC Triangle LUNGe Forward walk & week-long celebration with games, yoga, cooking and more.

Jennifer L. Garst, MD, a DCI thoracic medical oncologist at Duke Cancer Center Raleigh and professor of Medicine, has been named a Lung Cancer Hero by CURE Media Group.

In lieu of an in-person Evening of Hope Gala, the Lung Cancer Initiative will host an online live "Evening of Hope Auction and Celebration!"

The Duke Cancer Institute Virtual Grand Rounds Series, came to a successful summer close with its final session on June 19.

The research team found a signaling pathway within melanoma and other cancers that thwart the functioning of anti-PD-1 checkpoint inhibitors.

In a new Cell Reports paper, DCI researchers report they've uncovered actionable targets for the treatment of brain metastases harboring lung adenocarcinoma.

DCI was invited to join the elite international AACR Project GENIE consortium, whose registry contains clinical-grade cancer genomic sequencing data from nearly 71,000 patients & 80 major cancer types.

Life threw Chad Eddy “a curve ball" when a simple back pain escalated into something much bigger. Now, in recovery, he's giving back.

Anderson Garrett was working for a textile manufacturing company when in April 2006 her mother learned she had adenocarcinoma.

Michael Dorry, MD, is one of five recipients of an LCI Research Grant. Grantees are selected based on the impact of their proposal and commitment to the field.

There wasn’t much that could slow down Keith Nguyen, a Merck pharmaceutical employee who described himself as being “in perfect health.”

Dorothy Sipkins, MD, PhD, is developing a clinical trial of a new therapy that may force hidden breast cancer cells out of the bone marrow and back into the bloodstream.